KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Danaher (DHR) Research & Development (2016 - 2025)

Danaher (DHR) has 17 years of Research & Development data on record, last reported at $438.0 million in Q4 2025.

  • For Q4 2025, Research & Development fell 0.9% year-over-year to $438.0 million; the TTM value through Dec 2025 reached $1.6 billion, up 0.88%, while the annual FY2025 figure was $1.6 billion, 0.88% up from the prior year.
  • Research & Development reached $438.0 million in Q4 2025 per DHR's latest filing, up from $378.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $442.0 million in Q4 2024 and bottomed at $236.0 million in Q4 2022.
  • Average Research & Development over 5 years is $388.3 million, with a median of $397.0 million recorded in 2024.
  • Peak YoY movement for Research & Development: tumbled 36.62% in 2021, then soared 72.46% in 2023.
  • A 5-year view of Research & Development shows it stood at $251.0 million in 2021, then decreased by 5.98% to $236.0 million in 2022, then skyrocketed by 72.46% to $407.0 million in 2023, then grew by 8.6% to $442.0 million in 2024, then fell by 0.9% to $438.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $438.0 million in Q4 2025, $378.0 million in Q3 2025, and $403.0 million in Q2 2025.